Questions and Answers

1. Differences between the preparation and drugs and their positive interaction.
2. Regeneration time - why the cell cycle affects regeneration.
3. How the preparation affects individual systems.

What is the difference between a preparation and drugs?

Differences in the Mechanism of Action between Drugs and Preparations result from their nature, purposes and how they interact with the body. Drugs are usually synthetic compounds designed to specific effects on molecular targets (e.g. receptors, enzymes), while ATP preparation works more holistically, supporting natural energy processes and regenerative, which does not exclude the interaction of both substances.

1. Drugs: They act specifically by modulating signaling pathways. For example, inhibitors enzymes (e.g. statins inhibit HMG-CoA reductase, lowering cholesterol) or receptor agonists/antagonists (e.g. beta-blockers block adrenergic receptors, slowing down the heart). The effects are directed at the symptoms or causes of the disease, often with rapid effect, but may cause side effects.

2. ATP preparation: It works systemically, providing energy to cells (as a carrier energy and neurotransmitter), stimulating mitochondria to produce ATP more efficiently. This supports cellular regeneration, DNA repair and cell cycle control. (e.g. in cancer – repair of faulty cells; in hormonal disorders – glandular reconstruction). No specific target – effects are indirect, through improving bioenergetics, which leads to holistic regeneration.

Difference: Drugs target specific pathological mechanisms, the preparation enhances the natural repair processes – together they create a combination that guarantees the effectiveness of treatment and cellular reconstruction to completely eliminate the disease. The preparation supports the natural bioenergetics for long-term regeneration, does not accumulate to toxic amounts damaging or disrupting the functioning of organs. The preparation bypasses the rapid breakdown of natural ATP by integrating into the respiratory cycle cellular. Increases intracellular ATP without the typical PK ( pharmacokinetics) of drugs – It acts as an energy substrate and is not metabolized like drugs. The effects are cumulative. slower (3-6 months), through the regeneration of mitochondria and tissues.

Difference: Drugs manipulate PK for quick results, the preparation supports natural bioenergetics for long-term regeneration.


Why the best effects of pharmacological treatment and the use of the preparation Do they appear after 3 months?

Based on the analysis of biological mechanisms, pharmacokinetics (PK) and pharmacodynamics (PD), as well as documentation of the ATP preparation (where the effects, e.g. reduction of tumors or normalization of TSH, are visible after 3-6 months), let's explain why 3 months (approx. 90 days) is the standard period for visible, lasting effects. A similar relationship applies to cosmetics, where the skin renewal cycle and tissue adaptation require time.

1. In Pharmacological Treatment: Many drugs take time to accumulate in the body, adapt to receptors and change biological. It is not about immediate action (as in the case of antibiotics on infections), but about long-term modifications.

Time for Drug Accumulation and Stabilization: Drugs often have an elimination half-life (time where the concentration drops by half) from several days to weeks. To achieve a constant concentration therapeutic (steady-state), 4-5 half-lives are needed, which for many drugs takes 2-4 weeks. The full effects appear after 2-3 months, when the body adapts (e.g. changes in receptor expression). For example, in antidepressants (e.g. SSRIs like sertraline), the first effects (anxiety reduction) after 1-2 weeks, but full (changes in serotonin pathways, neuroplasticity) after 6- 12 weeks.

Biological Changes and Tissue Regeneration: Drugs affect processes that require time, e.g. cell regeneration (cell cycle lasts 24-72 hours, but full tissue renewal takes weeks/months). In statins (e.g. atorvastatin) cholesterol lowering effects visible after 2-4 weeks, but full protection cardiovascular after 3 months. In psychiatric therapy, synaptic remodeling and Neurogenesis (the creation of new neurons) requires 2-3 months. Individual Factors - metabolism, age, drug interactions influence - in older people effects .

2. In the use of the preparation The documentation shows the effects after 3 months (e.g. reduction of the prostate tumor from 16x10 mm to zero after 6 months, TSH decrease from 22 to 3.5 after 3 months). This is due to the mechanisms mitochondrial and cellular regeneration. Time for Mitochondria and Cell Regeneration: The preparation stimulates mitochondria to ATP production, which requires time for biogenesis (creation of new mitochondria via PGC- 1 α ) – the process takes 2-4 weeks at the cellular level, but full tissue regeneration (e.g. thyroid, prostate) – 3 months, because it includes cell cycles (renewal of the epithelium every 28-90 days) and DNA/ cell error repair. Increased ATP reduces oxidative stress (ROS), which accumulates, allowing apoptosis of damaged cells and proliferation of healthy cells – effects visible after 90 days. Systemic Adaptations - ATP as a neurotransmitter and hormonal regulator requires time to balance (e.g. normalization of hormones after 3 months). In ATP studies, the energy effects (e.g. in fatigue) stabilize after 8-12 weeks.

Why 3 Months?: This is a period of accumulation of changes, similar to pharmacology – metabolic adaptation and tissue.

3. In Cosmetics (90-Day Standard): The "90-day rule" in cosmetics is the time for visible effects, due to the biology of the skin. The skin renews itself cyclically, and changes accumulate. Skin Renewal Cycle - the epidermis is renewed every 28-30 days in young people, but the full cycle (in the deeper layers like the dermis with collagen) lasts 60-90 days. Cosmetics (e.g. retinol, Vitamin C) require time to penetrate, stimulate fibroblasts (collagen production) and pigmentation reduction – effects visible after 3 renewal cycles (90 days ).

Biological Mechanisms: Cosmetics affect cellular metabolism (e.g. increase ATP in keratinocytes), but collagen/elastin regeneration (wrinkle reduction) takes 3 months because fibroblasts they need time for synthesis (cycle ~28 days, but accumulation after 90). In studies, products like RoC show the effects of "9.6 years younger skin" after 90 days, because it time for adaptation and visible changes. By applying the preparation superficially, we ensure effective methods of skin regeneration, also in the context of acne skin lesions. To sum up, 3 months is the period for biological accumulation (adaptation, regeneration, cycles cellular), which ensures lasting effects. In the ATP preparation, as in pharmacology and cosmetics, it's time for mitochondrial and tissue renewal. ATP is designed to mimic the natural breathing cycle. cellular, using natural biological ingredients processed in specialized devices that simulate the functioning of cells. Its key task is stimulation of mitochondria – the "power plants of the cell" – to increase ATP production mitochondrial via oxidative phosphorylation. Laboratory results (e.g. from IMD Berlin) show that after 6 weeks of use, the ATP level in the blood increases by over 170% (from lower limit of normal to values typical for tissues with high demand energy, such as heart or skeletal muscles), which persists even after the end of therapy. In addition, the preparation supports the regeneration of mitochondria and protects them from damage. and oxidative stress .


THE EFFECT OF THE PREPARATION ON THE REGENERATION OF MUSCLE CELLS:

Regeneration of cardiomyocytes (heart muscle cells) is a limited process in adult mammals, where these cells lose the ability to proliferate (divide) after birth, entering a state of terminal differentiation. The ATP preparation, stimulating mitochondria for increased ATP production, supports this process through metabolic reprogramming, reduction of oxidative stress and modulation of mitochondrial dynamics. The mechanism is based on the stimulation of metabolism to more efficient oxidative phosphorylation. (OXPHOS), which restores the proliferative capacity while providing energy for repairs.

1. Mitochondrial Stimulation and ATP Production as the Basis of Regeneration.
Mitochondria in cardiomyocytes generate ~90% of the heart's ATP via OXPHOS (phosphorylation), but in conditions of damage (e.g. infarction, hypertrophy) their function decreases, leading to energy deficiency and apoptosis. ATP preparation, mimicking the natural cycle cellular respiration, increases intracellular ATP, maintaining membrane potential mitochondrial even with partial inhibition of OXPHOS. This creates a reserve energy, enabling regeneration without a bioenergetic crisis. High ATP with the preparation supports mitochondrial biogenesis (creation of new organelles via PGC-1 α ) and dynamics (fusion), which is crucial for reconstruction after damage.

2. Mitochondria in cardiomyocytes generate ~90% of the heart's ATP via OXPHOS (phosphorylation), but in conditions of damage (e.g. infarction, hypertrophy) their function decreases, leading to energy deficiency and apoptosis. ATP preparation, mimicking natural cycle of cellular respiration, increases intracellular ATP, maintaining mitochondrial membrane potential even with partial inhibition of OXPHOS. This creates an energy reserve that allows for regeneration without a crisis bioenergetic. High ATP from the preparation supports mitochondrial biogenesis (creation of new organelles via PGC-1 α ) and dynamics (fusion), which is crucial for reconstruction after damage.

3. Adult cardiomyocytes depend on oxidative phosphorylation. Stimulation of mitochondria ATP preparation leads to the supply of biosynthetic precursors (e.g. nucleotides, amino acids) necessary for cell division. Activation of phosphorylation promoting growth and proliferation without energy stress (no AMPK activation ), which hypermethylates DNA, upregulating heart developmental genes (e.g. muscle proliferation) and downregulating contractile genes. As a result, cardiomyocytes enter the cycle cell leading to hyperplasia (doubling of the number of cells) and migration of new cells to the injury zone (e.g. after a heart attack ).

4. Reduction of Oxidative Stress and DNA Damage Damaged cardiomyocytes accumulate ROS from ETC, which causes mtDNA damage, apoptosis and scarring. The preparation, by increasing ATP, minimizes electron leakage, activating antioxidants (e.g. SOD, catalase via NRF2) and reducing ROS by ~30. This protects mitochondrial and nuclear genome, reducing DNA damage. In conclusion, the ATP preparation promotes cardiomyocyte regeneration through energetic mitochondrial optimization, improved metabolism, ROS reduction and dynamics, which enables proliferation and repair.


EFFECT OF THE PREPARATION ON THE REGENERATION OF NERVE CELLS:

Mitochondrial regeneration in neurons refers to the processes by which neurons restore, renew, or optimize their mitochondrial population to maintain energy homeostasis, support synaptic function and promote axonal growth or repair. Neurons are highly dependent on mitochondria due to their polarized structure and high energy demand – mitochondria provide ATP to neurotransmission, axonal transport, and plasticity. Dysfunctional mitochondria contribute to neurodegeneration (e.g. Alzheimer's disease, Parkinson's disease), while Regenerative mechanisms enhance neuronal survival and repair.

1. Mitochondrial Biogenesis This is the basic mechanism of mitochondrial regeneration, involving the formation of new ones. organelles to replace damaged ones. It is regulated by gamma coactivator peroxisome proliferator-activated receptor 1-alpha (PGC-1 α ), which activates nuclear respiratory factors (NRF-1/2) for transcription of mitochondrial genes. In In neurons, biogenesis is triggered by energy stress or neuronal activity, ensuring the supply of ATP for growth and regeneration. Role of ATP: ATP acts as an energy sensor via AMP-activated kinase (AMPK), which detects low ATP/AMP ratios and activates PGC-1α to increase biogenesis. The preparation, increasing stable mitochondrial ATP, maintains high ATP levels, preventing energy deficits and promoting biogenesis in axons and synapses. This supports neuronal regeneration, e.g. after injury, by providing ATP for local protein synthesis and plasticity .

2. Mitochondrial Dynamics Neurons regulate the shape and arrangement of mitochondria through fusion stimulated by the amount of ATP, which enables the sharing of components (e.g. mtDNA, proteins) for repair purposes damaged mitochondria, while increasing the high-energy molecule isolates dysfunctional ones for removal. In regenerating axons, increased stimulation to ATP production facilitates the transport of mitochondria to growth cones. Low ATP disrupts dynamics, leading to neuronal fragmentation and death; preparation restores the optimally increased amount of ATP, enabling balanced dynamics and regeneration. For example, in axonal injury, ATP-dependent fusion complements healthy mitochondria, supporting repair.

3. Mitophagy (Selective Autophagy of Mitochondria) Damaged mitochondria are removed via mitophagy (PINK1/Parkin pathway), where PINK1 accumulates on depolarized mitochondria, recruiting Parkin to ubiquitination and engulfment by autophagosomes. This removes ROS-producing organelles, preventing neuronal damage and enabling the biogenesis of new mitochondria. Role of ATP: Mitophagy is ATP dependent (e.g. for autophagosome formation and fusion lysosomal). Energy deficits impair it, leading to the accumulation dysfunctional mitochondria; the preparation increases ATP, enhancing mitophagy in distal axons, crucial for regeneration after neurodegeneration.

4. Mitochondrial Transport Neurons transport mitochondria along axons via kinesin (anterograde) and dynein (retrograde), anchored by syntaphilin (SNPH). Regeneration requires rapid delivery to injury sites for ATP delivery. The preparation increases mitochondrial ATP, driving transport and preventing bioenergetic breakdown, which supports axonal regeneration (e.g. after nerve injury). In summary, mitochondrial regeneration in neurons is based on biogenesis, dynamics, mitophagy, transport and control of ROS (reactive oxygen species), all dependent on ATP. The preparation enhances these processes by increasing stable ATP, potentially supporting repair in neurodegenerative conditions, clinical evidence is developing.


EFFECT ON WOUND HEALING

Increasing mitochondrial ATP levels has a very beneficial, multi-stage effect on Wound healing – both at the cellular and tissue levels. The wound healing process proceeds in four overlapping phases (hemostasis, inflammatory, proliferative and remodeling), and mitochondria play a key role in them as a source of energy and stress regulator .

1. Preventing excessive inflammation and reducing oxidative stress Damaged cells and neutrophils produce large amounts of ROS (reactive oxygen species) from mitochondria and NADPH oxidase. Excess ROS damages tissues, delays healing and increases the risk of scarring. High levels of mitochondrial ATP stabilize the membrane mitochondrial, reduces electron leaks in the respiratory chain and activates enzymes antioxidants (SOD2, catalase, glutathione peroxidase via NRF2). This reduces ROS by 30–50%, which shortens the inflammatory phase and protects against further tissue damage. Activation and migration of immune cells – increased amount of ATP in granulocytes. Increased mitochondrial ATP in these cells provides energy for chemotaxis, phagocytosis and degranulation, accelerating the removal of pathogens and tissue debris. At the same time, high ATP supports rapid apoptosis of neutrophils, which prevents excessive inflammation.

2. Proliferative phase (3–21 days) – the strongest influence of ATP Keratinocytes and fibroblasts require enormous amounts of ATP for division, migration and synthesis. extracellular matrix proteins (collagen, elastin, fibronectin). Increased mitochondrial ATP (OXPHOS) provides energy for these processes, accelerating re-epithelialization (wound closure) and matrix reconstruction. Studies show that taking the preparation affects the stimulation of mitochondria and increases the proliferation of keratinocytes by 40–60% and shortens the re-epithelialization time by 30–50%. ATP stimulates the production of VEGF (vascular endothelial growth factor) and NO (nitrogen monoxide) nitrogen - a key gas molecule in tissue communication) by improving the function endothelium. Mitochondria in endothelial cells use increased ATP to synthesis of these factors, which accelerates the formation of new blood vessels. crucial for delivering oxygen and nutrients to the wound. Fibroblasts need ATP to synthesize procollagen and convert it into collagen. mature. High mitochondrial ATP increases proline and lysine hydroxylase activity, improving collagen quality and reducing the risk of hypertrophic scarring.

3. Remodeling phase (3 weeks – 1–2 years) Reduction of scarring and improvement of scar quality Increased ATP supports the balance between MMPs (matrix metalloproteinases) and TIMPs (inhibitors), which allows for better collagen remodeling (from type III to type I). This leads to more flexible, less visible scar. Long-term regeneration ATP supports mitochondrial biogenesis (PGC-1α ) and mitophagy (PINK1/Parkin), which restores the pool of mitochondria in skin cells, ensuring long-term resistance to stress and better healing in subsequent injuries.


MECHANISM OF ACTION OF INCREASED MITOCHONDRIAL ATP IN THERAPY CANCER:

Increasing mitochondrial ATP levels (by stimulating mitochondria preparation) affects cancer cells and the tumor microenvironment in several key ways levels. These mechanisms result from the fact that cancer cells often have dysfunctional mitochondria and rely mainly on glycolysis (Warburg effect), and high mitochondrial ATP restores or modifies their metabolism, signaling and cell fate.

1.Direct effect on cancer cells: Energy overload and apoptosis induction Cancer cells often have reduced OXPHOS capacity and limited reserve energy. A sudden and sustained increase in mitochondrial ATP (e.g. from 2–3 µM to 7–8 µM, as in documentation) can lead to overloading of the mitochondria of cancer cells: * increased proton gradient → excessive ROS production (especially in cells with damaged complex I/III), - opening of mPTP (mitochondrial permeability transition pore), - release of cytochrome c → activation of caspases 9 and 3 → intrinsic apoptosis. - Changing metabolism makes it possible to overcome the Warburg effect High mitochondrial ATP inhibits glycolysis (feedback inhibition of PFK-1 and LDH) and restores OXPHOS. This reduces the production of biosynthetic precursors (nucleotides, lipids), which are necessary for the rapid proliferation of cancer cells → this guarantees a slowdown in the cycle cell division and a reduction in the rate of division.

Activation of proapoptotic pathways:
Increased ATP stabilizes p53 (by decreasing MDM2), which activates genes proapoptotic (PUMA, NOXA, BAX). Additionally, high mitochondrial ATP reduces expression of antiapoptotic Bcl-2/Bcl-xL proteins.

2. Impact on the tumor microenvironment (TME) through purinergic signaling:

Increased ATP production in tumor cells and healthy cells leads to release of ATP into the microenvironment. High ATP concentration (especially >100–500 µM) activates P2X7 receptors on cancer and immune cells:
In cancer cells →opening of macropores → causes massive influx of Ca²⁺ → mitochondrial overload → apoptosis/necroptosis. In immune cells (macrophages, DCs, T lymphocytes) → inflammasome activation 1β /IL-18 production → immunogenic cell death (ICD), recruitment and activation of NK and CD8 + T cells.

High eATP and mitochondrial ATP in macrophages promote M1 polarization (pro-inflammatory, anti-cancer) instead of M2 ( pro-cancer ). This leads to increased phagocytosis cancer cells and IFN- γ /TNF- α production . High ATP reduces the activity of suppressor cells (MDSC, Treg) by modulation of A2A/A2B receptors (adenosine produced from ATP has an immunosuppressive effect, but at high ATP the pro-inflammatory effect of P2X7 dominates ).

3. Selectivity mechanisms – why do healthy cells not undergo apoptosis?

Healthy cells have high mitochondrial reserve and efficient mitophagy → they cope better cope with high ATP and ROS. Cancer cells often have damaged mitochondria (mtDNA mutations, reduced OXPHOS) → are more sensitive to energy overload and ROS. The ATP preparation supports mitochondrial biogenesis (PGC-1 α ) in healthy cells, which additionally protects them and enhances tissue regeneration.

Summary of key mechanisms:
In cancer cells: mitochondrial overload → ROS increase → mPTP opening → internal apoptosis. In the tumor microenvironment: high eATP → P2X7 activation → ICD + cell recruitment NK/T + polarization M1. In healthy cells: support for mitochondrial biogenesis and function → regeneration and protection against damage. As a result, the drug does not "kill" the cancer directly like chemotherapy, but restores cancer cells proper metabolism and signaling, which leads to their selective elimination while supporting the regeneration of healthy tissues and improving the signaling and functioning of the immune system.

HOW A PREPARATION THAT INCREASES MITOCHARDIAL ATP SUPPORTS CHEMOTHERAPY TREATMENT AND RADIOTHERAPY?

Based on the mechanisms previously described, including the role of mitochondria in metabolism energy, apoptosis, purinergic signaling via the P2X7 receptor and dysfunction mitochondrial in cancer), a preparation that stabilizes and increases the level of ATP supports chemotherapy and radiotherapy at several levels. The documentation indicates systemic the action of the preparation – cellular repair, improvement of the efficiency of the cell cycle and mitochondrial energy production – which synergizes with conventional therapies. Although documentation does not directly describe the combination with chemo/radio, scientific research suggest mechanisms by which increasing mitochondrial ATP may increase the effectiveness of these therapies while reducing their toxicity to healthy tissues.

1. Enhancement of apoptosis in cancer cells (synergy with chemo/ radio):
Chemo (e.g. cisplatin, doxorubicin) and radio induce apoptosis mainly through the pathway internal (mitochondrial): cause DNA damage, oxidative stress and mitochondrial membrane permeabilization (MOMP), which leads to the release of cytochrome C, activation of caspases and cell death. Cancer cells often avoid apoptosis by mitochondrial resistance (e.g. overexpression of Bcl-2, Warburg effect with dominance glycolysis). A preparation that increases mitochondrial ATP may enhance this process by activating P2X7 receptor: high levels of extracellular ATP – resulting from increased intracellular production – they open P2X7R macropores, causing a massive influx of Ca²⁺ into mitochondria. This leads to depolarization of the mitochondrial membrane, an increase in ROS, release of cytochrome C and enhancement of the apoptotic pathway. As a result, cancer cells become more sensitive to chemo/radio-induced damage, which reduces resistance to pharmacology – which is a very common problem in pharmacological treatment. Examples from research: In the context of high ATP and stimulating mitochondria to its production (as in the preparation), we obtain the biphasic effect of P2X7 macropores – at high concentrations – induces cytotoxicity, synergizing with radio (e.g. increasing the immunogenicity cell death). The documentation emphasizes the repair of "damaged cells" in cancer, which means selective induction of apoptosis in those with mitochondrial defects.

2. Improvement of mitochondrial function in healthy cells (reduction of toxicity chemo/ radio)
Chemo and radio cause side toxicity (e.g. cardiotoxicity, neurotoxicity, fatigue), mainly through mitochondrial damage in healthy tissues: an increase ROS, decreased ATP production, and OXPHOS phosphorylation dysfunction. This leads to fatigue, nausea and immunosuppression. The preparation, by increasing mitochondrial ATP, improves the efficiency of OXPHOS, reduces stress oxidative and supports regeneration. In healthy cells, higher ATP stabilizes mitochondria, increases their resistance to damage (e.g. through better biogenesis and reduction of ROS), which allows for faster tissue regeneration after therapy.

Examples: Studies show that supporting mitochondrial metabolism in healthy cells (e.g. mitochondrial antioxidants or energy supplementation) reduces chemo/radio toxicity by improving ATP and electron chain function transport – only possible with intact mitochondria. The advantage preparation over classical supplementation is the fact that even in a state of high toxicity and advanced mitochondrial damage, the preparation reverses the damage, protects and stimulates mitochondria. In the context of the preparation, its systemic action (repair at the cellular level) could protect healthy tissues, allowing for higher doses of chemo/radio without side effects.

3. Counteracting resistance to treatment:

Many cancers develop resistance to chemo/radio through dependence on mitochondrial OXPHOS. The Warburg effect masks this, but some of the mitochondria in cancer cells remain functional, supporting survival. Elevating ATP through mitostimulation selectively exacerbates dysfunction in cells tumor: high intracellular ATP also increases in the tumor microenvironment, activating P2X7R and NLRP3 inflammasome, leading to a pro-inflammatory response immune and apoptosis. This synergizes with chemo/radio, which induces immunogenic cell death (ICD), enhancing the anti-tumor response. The preparation supports chemo/radio by: - induction of apoptosis of cancer cells due to activation of the P2X7 receptor and mitochondrial stress in these cells (overload due to the fact that mitochondria remaining in cancer cells will be more easily destroyed overloaded by increased ATP from much more efficient phosphorylation healthy cells), - protection of healthy tissues by improving the functioning and structure of mitochondria, will translate into more efficient phosphorylation and increased ATP production, - resistance reduction. This is consistent with the documentation (repair at the level cellular, ATP increase to healthy tissue levels). However, the effects are dependent depending on the quantity, too low ATP levels may paradoxically partially support immunity cancer with low P2X7 activation, so dosage is key.

DEPENDENCE ON THE LIMITATION AND WITHDRAWAL OF AUTOIMMUNE PROCESSES THANKS TO MITOCHONDRIA STIMULATION AND INCREASING ATP

Based on the documentation of the ATP preparation (repair of damaged cells, reconstruction organs at the cellular level, cell cycle regulation) and knowledge about pathophysiology of autoimmunity, the mechanism of action is as follows:

1. The key role of mitochondrial dysfunction in autoimmunity:

In autoimmune diseases (Hashimoto's, psoriasis, rheumatoid arthritis, lupus) mitochondria in target cells (thyrocyte, keratinocyte, synoviocyte, immune cells) are dysfunctional because they occur: - increased production of ROS (reactive oxygen species – excess damages DNA, mitochondria), - mtDNA damage (mutations and changes in the cell leading to changes in the area cells and mitochondrial diseases), - reduced ATP production, - activation of the NLRP3 inflammasome (protein signaling complex), - release of oxidized mtDNA as autoantigen (DAMP – the reason why the immune system attacks its own tissues), - loss of immunological tolerance. This leads to the activation of autoreactive T lymphocytes and the production of pro-inflammatory cytokines. (IL-1 β , IL-6, IL-17, TNF- α ) and destruction of own tissues.

2. How Increasing Mitochondrial ATP Breaks This Cycle; ATP preparation, stimulating mitochondria to effectively produce ATP (increase by over 170% in blood, IMD labor tests), works on several levels: - Reduction of oxidative stress (ROS), - Higher ATP stabilizes the respiratory chain → reduces electron leakage → decrease in ROS by 30–50%. Less ROS = less NLRP3 activation and smaller mtDNA damage → fewer autoantigens (oxidized mtDNA, proteins mitochondrial) → weakening of the autoimmune response. - Inhibition of the NLRP3 inflammasome High mitochondrial ATP blocks NLRP3 oligomerization (by stabilizing mitochondrial function and reducing ROS). This limits the production of IL-1β and IL-18 – key cytokines in Hashimoto, psoriasis and RA → reducing inflammation and attack on own tissues. Improving target cell function and restoring tolerance Increased ATP supports mitochondrial biogenesis (PGC-1α ) and mitophagy (PINK1/Parkin) in thyrocytes, keratinocytes, synoviocytes → reconstruction of damaged cells and reducing the expression of autoantigens. Healthy cells with high ATP present better antigens in a tolerogenic manner (e.g. more PD-L1), which inhibits the activation of autoreactive T lymphocytes Increased intracellular ATP leads to controlled release of eATP → activation of P2X7 and P2Y receptors in a physiological manner (low–medium concentrations) → inhibiting Th17 and promoting Treg (regulatory T cells), which restores balance High concentrations of eATP (as in the preparation) induce apoptosis autoreactive T and B lymphocytes. Systemic effect – restoration of barrier and homeostasis - In the thyroid gland: regeneration of thyrocytes → normalization of hormone production → decrease TSH and antibodies (Anti-TPO). - In psoriasis: keratinocyte regeneration → reduction of hyperproliferation and inflammation → plate withdrawal. - In RA: reconstruction of synoviocytes and cartilage → reduction of erosion and pain.

To summarize why autoimmunity is retreating:

Increasing mitochondrial ATP acts as an “energy reset”: • removes the main trigger of inflammation (ROS + damaged mtDNA), - inhibits key pro-inflammatory pathways (NLRP3, Th17), - restores immunological tolerance (Treg, PD-L1), - enables regeneration of target tissues (mitochondrial biogenesis, repair cellular). As a result, the body gradually regains control over the immune response – instead of attacking its own tissues, it begins to regenerate them. This explains the observed documentation of rapid antibody declines, hormone normalization and symptom relief autoimmune diseases after 1–3 months of use. The mechanism is natural and systemic, which distinguishes it from classic immunosuppressive drugs.

INCREASING MITOCHONDRIAL ATP AFTER PHYSICAL EXERCISE

After intense training, skeletal muscles use huge amounts of ATP – the ATP pool and phosphocreatine (PCr) drops by as much as 70–90% within minutes. The body must quickly rebuild these resources, remove by-products (lactate, H⁺ ions, ROS) and repair microdamage. Increased mitochondrial ATP levels (e.g. thanks to the preparation stimulating mitochondria) accelerates and deepens this process on several key levels.

1. Faster and more complete restoration of the energy pool.
Mitochondria rapidly resynthesize ATP from ADP and Pi and also regenerate phosphocreatine (PCr) via mitochondrial creatine kinase (mi-CK). Higher mitochondrial ATP = faster and more efficient transport of ADP into the matrix oxidative phosphorylation → PCr regeneration time shortens from 3–5 minutes to 1–2 minutes (much faster return to high intensity in training series or between intervals ).

2. Reduction of acidification and faster lactate removal.
Increased mitochondrial efficiency allows for faster lactate oxidation → lower blood lactate level at the same intensity. Less H⁺ ions = less acidification → delayed peripheral fatigue and faster return to rest.

3. Reduction of oxidative stress and mitochondrial damage.
Intense exercise causes an increase in ROS from complexes I and III. High ATP stabilizes the membrane mitochondrial, reduces electron leaks and activates NRF2 → increase in SOD2, catalase and glutathione.
Effect:less mtDNA and protein damage → faster mitochondrial regeneration after training (biogenesis + mitophagy ).

4. Accelerated protein synthesis and repair of microdamages.
ATP is necessary for mRNA translation (ribosomes), mTORC1 activation, and protein synthesis contractile (actin, myosin). Higher mitochondrial ATP = higher protein synthesis efficiency after strength training (24–72 h window) → faster supercompensation, increased strength and muscle mass.

5. Better energy regeneration and reduced central fatigue.
ATP supports the Ca²⁺ pump (SERCA) in the sarcoplasmic reticulum → faster recovery calcium → less muscle fatigue. Improved ATP in neurons and sympathetic/parasympathetic nervous system → better autonomic regulation, less central fatigue and faster return to homeostasis after effort.

Summary:
Increasing the amount of ATP in the body and stimulating mitochondria with the preparation affects shortening the recovery time between sets and training units. It also reduces DOMS (delayed onset muscle soreness) – which is why it is 1–2 days shorter. Stimulation with the preparation also influences the faster reconstruction of PCr and ATP – return to high levels intensity in a shorter time. Additionally, less acidification and faster removal lactate. Better protein synthesis and regeneration of micro-damages ensured by protection and stimulation of mitochondria with the preparation. What is also important - reduced risk overtraining (better autonomic balance, lower cortisol, better sleep). In practice, this means that the athlete can train more often, more intensely and with less the risk of overtraining, and regeneration after hard sessions or competitions is faster and more effectively. The strongest effects are visible after 4–12 weeks of regular use. use of the preparation when mitochondria undergo actual reconstruction and increase in density.

MECHANISM STIMULATED BY ATP FOR STRENGTHENING CONCENTRATION AND INTELLECTUAL WORK.
preparation , as a stabilized analogue of adenosine-5' - triphosphate, acts systemically, stimulating mitochondria to increase mitochondrial ATP production (through oxidative phosphorylation is enhanced). ATP is a source of energy for the nervous system and neurotransmitter, which directly affects cognitive functions. Based on observations scientific, strengthens concentration, reaction time and intellectual performance, especially after exertion or in conditions of fatigue.

1.Increased Mitochondrial Energy Production in Neurons (Improvement Bioenergetic Efficiency ).
Mitochondria in nerve cells (neurons and glia) are crucial for maintaining high energy demand of the brain (approx. 20% of the body's total ATP). The preparation increases the level of intracellular ATP (studies from IMD Labor) , ensuring energy for processes such as maintaining membrane potential, synthesis neurotransmitters (e.g. acetylcholine, dopamine) and synaptic plasticity (learning, memory ).
The mechanism involves the stimulation of the respiratory chain in mitochondria, thanks to which increasing the proton gradient and ATP synthase activity, which reduces fatigue cognitive. Studies show that increasing the amount of ATP prevents the decline in the reaction after intense exercise, improving cognitive functions by 24% (applies to stimulating mitochondria to produce ATP more efficiently) . This supports focus by stabilizing energy for the prefrontal cortex (responsible for attention and planning ).

2. Modulation of Purinergic Neurotransmission (As a Neurotransmitter ).
ATP acts as a neurotransmitter in the nervous system by binding to P2X and P2Y receptors, which regulates synaptic transmission, dopamine and glutamate release (crucial for motivation and learning). The preparation increases the availability of stable ATP, strengthening signaling in brain circuits related to attention (e.g. mesolimbic system). High levels of ATP activate P2X7, which improves reaction time and reduces errors in visuomotor tasks. In studies, just 14 days of ATP supplementation improved the response time and reduced errors after intellectual and physical exertion, suggesting a reduction cognitive dysfunction after activity. Strengthening and stimulating mitochondria to increased ATP production intensifies intellectual work through better modulation attention and information processing.

3.Improvement of Cerebral Circulation and Oxygen Supply (Vasodilation and Protection Against Hypoxia - dilation of blood vessels and protection against tissue hypoxia ).
The preparation increases the amount of ATP in the bloodstream, which stimulates the production of nitric oxide (NO) and dilates blood vessels, improving blood flow to the brain (cerebral blood flow). This provides better nourishment to neurons, reducing " brain fog" and supporting function executive ).
Mitochondrial stimulation reduces oxidative stress (ROS), protecting mitochondria in neurons from damage, which keeps ATP stable. Meta-analyses indicate that ATP improves reaction time, memory and IQ, especially in conditions of fatigue. In the context of intellectual work, increasing the level of mitochondrial ATP stimulates focus through better oxygenation of the prefrontal cortex .

4. Reduction of Oxidative Stress and Neuroprotection (Protection of Nerve Cells)
High mitochondrial ATP reduces ROS production in the electron chain, protecting neurons against oxidative damage that causes a decrease in concentration (e.g. in aging or stress). Astrocytic ATP (via A1 receptors) regulates deficits memory in the event of sleep deprivation, restoring synaptic plasticity in the hippocampus.
The preparation supports mitochondrial biogenesis (creation of new ones), which increases resistance to fatigue. Studies on the preparation show that it reduces errors in cognitive tasks after exercise, improving mental clarity and reaction, thus supporting work intellectual through long-term protection against neural degeneration.
In summary, the ATP preparation enhances concentration and intellectual work by energetic and signaling stimulation of the brain, especially after exercise. Effects are documented in the literature .